The FDA’s draft guidance on CBD enforcement policy was submitted for review by the White House Office of Management and Budget (OMB) and the OMB has now scheduled meetings with various hemp/CBD stakeholder groups
Written by CannIntelligence || 3rd August 2020 || News analysis | Regulation and legislation | North America United States